NCT01881997

Brief Summary

Patients presenting with painful procedures in the Emergency Department (ED) have been shown to frequently have inadequate pain management. The incision and drainage (I\&D) of an abscess is a common procedure that is viewed by many emergency physicians as only requiring a localized anesthetic for pain management. However, it has been documented in previous research that there can be disconnect between what emergency medicine physicians interpret as painful and what patients experience as pain. A trial will be conducted to focus on use of intramuscular (IM) Fentanyl as an intervention to help alleviate pain associated with the incision and drainage of an abscess. This is a procedure that rarely receives systemic opioids. This double blinded protocol will randomize a total of 50 patients patients with abscesses to receive either a combination of Fentanyl IM followed by subcutaneous (SC) local bupivicaine analgesia or Normal Saline IM followed by SC local bupivicaine analgesia. Only opiate naive patients will be enrolled. The primary outcomes studied are patients overall satisfaction with procedure, and patients level of pain associated with the procedure.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2011

Shorter than P25 for phase_4

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 1, 2011

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2011

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
1.6 years until next milestone

First Posted

Study publicly available on registry

June 20, 2013

Completed
Last Updated

June 20, 2013

Status Verified

June 1, 2013

Enrollment Period

6 months

First QC Date

April 1, 2011

Last Update Submit

June 17, 2013

Conditions

Keywords

ProcedureAbscessEmergency DepartmentOpioidFentanyl

Outcome Measures

Primary Outcomes (2)

  • Highest level of pain during the incision and drainage of the abscess

    After the procedure the following question will be asked via a survey: On a scale of 1-10 with 10 being the worst possible pain, what was your highest level of pain during the incision and drainage of the abscess? The answer will be collected via a visual analog scale.

    Participants will be followed for the duration of hospital stay

  • Safety of Intramuscular Injection of Fentanyl

    All patients will be monitored to see if any of the following occur after administration of Fentanyl: Adverse effects * decreased oxygen saturation \<95% * respiratory depression * bradycardia * hypotension * anaphylaxis or laryngospasm or bronchoconstriction * muscle rigidity * other: Side effects * nausea * itching * drowsiness Treatment needed * O2 * IV Fluids * Medications: Specify name and dose * Other, specify:

    Participants will be followed for the duration of hospital stay

Study Arms (2)

Normal Saline

PLACEBO COMPARATOR

IM normal saline

Drug: Normal Saline

Fentanyl

EXPERIMENTAL

IM Fentanyl

Drug: Fentanyl

Interventions

Fentanyl Intramuscular (IM), 1ugm/kg, x1

Fentanyl

IM normal saline

Normal Saline

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \>18 and \< 65 years
  • Presenting with a simple abscesses requiring incision and drainage
  • Treating physician has to state that the patient's usual treatment would not include systemic opioids before incision and drainage.

You may not qualify if:

  • Patients are unable to consent to procedure the procedure
  • Patients are less than age 18 or older than age 65
  • Patients are unable to avoid driving for 2 hours after administration of the intramuscular medication (Fentanyl or placebo)
  • Patients have hypersensitivity or allergy to Fentanyl
  • Patients are pregnant
  • Patients have taken a narcotic pain medication in the last 14 days
  • Patients have a history of drug or alcohol addiction
  • Patients have taken an monoamine oxidase (MAO) inhibitor in the last 14 days (such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate)
  • Patients have a breathing disorder such as chronic obstructive pulmonary disease
  • Patients have a history of head injury or brain tumor
  • Patients have a heart rhythm disorder
  • Patients have seizures or epilepsy
  • Patients have mental illness such as depression, hallucinations
  • Patients have low blood pressure
  • Patients have liver or kidney disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (10)

  • Wilson JE, Pendleton JM. Oligoanalgesia in the emergency department. Am J Emerg Med. 1989 Nov;7(6):620-3. doi: 10.1016/0735-6757(89)90286-6.

  • Fosnocht DE, Swanson ER, Bossart P. Patient expectations for pain medication delivery. Am J Emerg Med. 2001 Sep;19(5):399-402. doi: 10.1053/ajem.2001.24462.

  • Motov SM, Khan AN. Problems and barriers of pain management in the emergency department: Are we ever going to get better? J Pain Res. 2008 Dec 9;2:5-11.

  • Downey LV, Zun LS. Pain management in the emergency department and its relationship to patient satisfaction. J Emerg Trauma Shock. 2010 Oct;3(4):326-30. doi: 10.4103/0974-2700.70749.

  • Yanuka M, Soffer D, Halpern P. An interventional study to improve the quality of analgesia in the emergency department. CJEM. 2008 Sep;10(5):435-9. doi: 10.1017/s1481803500010526.

  • Fry M, Holdgate A. Nurse-initiated intravenous morphine in the emergency department: efficacy, rate of adverse events and impact on time to analgesia. Emerg Med (Fremantle). 2002 Sep;14(3):249-54. doi: 10.1046/j.1442-2026.2002.00339.x.

  • Schechter NL, Weisman SJ, Rosenblum M, Bernstein B, Conard PL. The use of oral transmucosal fentanyl citrate for painful procedures in children. Pediatrics. 1995 Mar;95(3):335-9.

  • Weisman SJ, Bernstein B, Schechter NL. Consequences of inadequate analgesia during painful procedures in children. Arch Pediatr Adolesc Med. 1998 Feb;152(2):147-9. doi: 10.1001/archpedi.152.2.147.

  • O'Malley GF, Dominici P, Giraldo P, Aguilera E, Verma M, Lares C, Burger P, Williams E. Routine packing of simple cutaneous abscesses is painful and probably unnecessary. Acad Emerg Med. 2009 May;16(5):470-3. doi: 10.1111/j.1553-2712.2009.00409.x. Epub 2009 Apr 10.

  • Curtis KM, Henriques HF, Fanciullo G, Reynolds CM, Suber F. A fentanyl-based pain management protocol provides early analgesia for adult trauma patients. J Trauma. 2007 Oct;63(4):819-26. doi: 10.1097/01.ta.0000240979.31046.98.

MeSH Terms

Conditions

AbscessEmergencies

Interventions

FentanylSaline Solution

Condition Hierarchy (Ancestors)

SuppurationInfectionsInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsDisease Attributes

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Officials

  • Larry J Baraff, MD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR
  • Joshua W Elder, B.S.

    University of California, Los Angeles

    STUDY DIRECTOR
  • Adaira Landry, B.A.

    University of California, Los Angeles

    STUDY DIRECTOR
0

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 1, 2011

First Posted

June 20, 2013

Study Start

June 1, 2011

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

June 20, 2013

Record last verified: 2013-06